131

Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores

Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Penis cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores

Penis disease spectrum (penis tumor progression) tissue array, 59 cases/60 cores

Penis disease spectrum tissue array, including TNM, clinical stage and pathology grade, 208 cases/ 208 cores

Peripheral nerve tumor tissue array, including TNM and clinical stage, 50 cases/100 cores, replacing SO1001

Pleomorphic liposarcoma tissue array, 30 cases/30 cores

Poorly differentiated breast cancer tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores

PR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases/11 cores

Progression of gastric carcinoma tissue array: normal gastric mucosa tissue, distal gastric mucosa tissue, adjacent gastric mucosa tissue, primary focus of gastric cancer, hepatic metastases of...

Progression of gastric carcinoma: normal gastric mucosa tissue, distal gastric mucosa tissue, adjacent gastric mucosa tissue, primary focus of gastric

Progression of liver carcinoma, 40 cases, 1 core/case.

Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases/80 cores

Prostate adenocarcinoma, 100 cases.

Prostate cancer and hyperplasia tissue array, including TNM and Gleason grade, 75 cases/75 cores, replacing PR753

Prostate cancer and hyperplasia tissue array, including TNM, clinical stage and pathology grade, 32 cases/ 63 cores, replacing BC19017

Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases/80 cores, replacing BC19019

Prostate cancer test tissue array, including TNM and Gleason grade, 12 cases/24 cores, replacing T195d

Prostate cancer test tissue array, including TNM, Gleason score and pathology grade, 12 cases/24 cores, replaced by T195e

Prostate cancer tissue array (4x (2x3) array)���including TNM and pathology grade, 6 cases/24 cores, replacing T196a

Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing PR243b

Prostate cancer tissue array with cancer adjacent tissues, including WHO grade, gleason grade, gleason score, TNM and stage info, 24 cases/72 cores

Prostate cancer tissue array with unmatched normal prostate tissues, 24 cases/48 cores, with grades, stages and Gleason scores

Prostate cancer tissue array, 24 cases/48 cores

Prostate cancer tissue array, 48 cases/96 cores

Prostate cancer tissue array, 90 cases/150 cores

Prostate cancer tissue array, 90 cases/180 cores

Prostate cancer tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 80 cases/80 cores, replaced by PR803e

Prostate cancer tissue array, including TNM and pathology grade, 25 cases/100 cores

Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replaced by PR483c

Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases/63 cores, replacing PR8010

Prostate cancer tissue array, including WHO standerd grade, Gleason grade, Gleason score, TNM and clinical stage, 24 cases/48 cores, replacing PR484

Prostate cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 28 cases/72 cores, replacing BC19021

Prostate cancer tissue array, with pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 64 cases/192 cores, replacing PR208

Prostate cancer tissue array,99 cases, 81 cases have tumor and matched NAT.

Prostate cancer with adjacent normal tissue and normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 96 cases/192 cores, replacing PR1921b

Prostate cancer with normal prostate tissue array, including TNM, pathology grade and gleason score, 24cases/48 cores, replacing PR482a

Prostate cancer with normal prostate tissue array, including TNM, pathology grade, Gleason grade and gleason score, 24cases/48 cores, replaced by PR482b

Prostate cancer with normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 48 cases/48 cores, replacing PR483b

Prostate cancer with normal tissue array, including WHO grade, Gleason grade, Gleason score, TNM and clinical stage, 40 cases/80 cores, replacing PR808

Prostate cancer with prostate tissue array, including pathology grade, Gleason grade, Gleason score, TNM, clinical stage and PSA data, 96 cases/192 cores, replaced by PR1921c

Prostate cancer, hyperplasia and prostate tissue array, including TNM and Gleason grade, 80 cases/80 cores, replacing PR807b

Prostate cancer, hyperplasia with normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 21cases/63 cores

Prostate cancer,90 cases with tumor and matched NAT.

Prostate cancer,97 cases, 81 cases have tumor and matched NAT.

Prostate carcinoma tissue array, 9 cases/27 cores

Prostate carcinoma tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing T191

Prostate disease spectrum tissue array, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 80 cases/80 cores, replacing PR8011a

Prostate intraepithelial neoplasia and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores

Prostate tumor test tissue array, with normal prostate tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases/24 cores,replacing T193

Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases/63 cores, with grade and Gleason scores, replacing BC19014

Pulmonary interstitial fibrosis tissue array, 28 cases/56 cores

Rat (Normal)-RaFPT

Rat brain tissue array, 30 cases/30 cores

Rat multiple organs normal tissue array, 36 cases/90 cores, replacing RAT901

Rat multiple organs normal tissue array, 49 rats/160 cores

Rat normal heart test tissue array, 6 cases/24 cores

Rat normal kidney test tissue array, 6 cases/24 cores, replaced by TR071a

Rat normal kidney tissue array, 6 cases/24 cores, replacing TR071

Rat normal liver test tissue array, 6 cases/24 cores

Rat normal lung test tissue array, 6 cases/24 cores

Rat(Wistar strain) normal tissue array, covering all major organs, non-overlapping with ART662, 22 cases/66 cores

Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases/72 cores, replacing BS06031

Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases/72 cores, replacing BS06041

Rectal cancer and normal tissue array, non-overlapping with REC961,48 cases/96 cores

Rectal cancer and normal tissue array, with TNM and grade info, 73 cases/80 cores

Rectal cancer mid-density tissue array, non-overlapping with REC1501 or REC1503, 75 cases/150 cores

Rectal cancer mid-density tissue array, non-overlapping with REC1502 or REC1503, 75 cases/150 cores

Rectal cancer test tissue array with unmatched normal adjacent tissues, 12 cases/24 cores

Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores

Rectal cancer tissue array (90 cases) and matched normal adjacent tissue, with survival data

Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases/72 cores, replacing BC06022

Rectal cancer tissue array with normal tissue from autopsy, 40 cases/80 cores, with grade and stage data

Rectal cancer tissue array with normal tissues from autopsy, with TNM and grade data, 80 cases/80 cores

Rectal cancer tissue array, 102 cases/102 cores

Rectal cancer tissue array, with matched adjacent normal tissue, 40 cases/80 cores

Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases/80 cores

Rectal normal adjacent tissue and cancer tissue array, 74 cases/80 cores

Rectum adenocarcinoma (90 cases), tumor and matched NAT.

Rectum adenocarcinoma tissue array with matched NAT.

Rectum adenocarcinoma tissue array, 32 cases.

Rectum adenocarcinoma tissue array, including TNM and pathology grade, 216 cases/216 cores

Rectum adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores

Rectum adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores

Rectum adenocarcinoma tissue microarray with survival information, with matched normal adjacent tissue, 90 cases/180 cores

Rectum adenocarcinoma tissue microarray with survival information, with matched normal adjacent tissue, 90 cases/180 cores;

Rectum cancer and normal tissue array, 16 cases/48 cores

Rectum cancer and normal tissue array, non-overlapping with REC962, 48 cases/96 cores

Rectum cancer high density tissue array, 228 cases/228 cores

Rectum cancer high-density (200 core) tissue array, 192 cases/208 cores

Rectum cancer mid-density tissue array, non-overlapping with REC1501 or REC1502, 75 cases/150 cores

Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Rectum cancer tissue array with matched adjacent normal rectum mucosa tissue, including pathology grade, TNM and clinical stage, 39 cases/130 cores.

Rectum cancer tissue array with matched adjacent normal rectum tissue, including pathology grade, TNM and clinical stage, 75 cases/150 cores.

Rectum cancer tissue array with matched cancer adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores

Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases/102 cores

Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores

Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases/208 cores

Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases/72 cores